Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CV9201 proven effective in NSCLC: CureVac study
The trial was intended to test the safety and toxicity of CV9201, besides its ability to induce antigen-specific humoral and cellular immune responses in cancer patients. The trial
The trial was intended to test the safety and toxicity of CV9201, besides its ability to induce antigen-specific humoral and cellular immune responses in cancer patients. The trial
Realize, a randomised, double-blind, placebo-controlled Phase 3 trial compared the efficacy, safety and tolerability of telaprevir in 662 patients with chronic genotype-1 HCV who failed prior treatment with
Prolia is a therapy for the treatment of postmenopausal women with osteoporosis that specifically targets RANK Ligand, an essential regulator of osteoclasts. The treatment over three years led
The double-blind, randomized, placebo-controlled Phase 2a study of VX-509 enrolled 204 people with active moderate to severe RA. The study evaluated four dose levels of VX-509, which was
The new five-year data from the open-label phase of two pivotal Phase 3 clinical trials indicated that Viread maintains long-term viral suppression of HBV and reduces liver fibrosis
The company will start evaluating new sources and distributors for the nutrients it needs to develop and distribute all-natural medicine formulas for treating specific wellness issues. NTRR CEO
Xarelto, an once-daily oral dosing anticoagulant, works by blocking the Xa blood clotting factor. The approval of Xarelto is backed by the pivotal double-blind Phase 3 ROCKET AF
Idera chairman and CEO Sudhir Agrawal said they have prioritized key areas for their internal investments following a thorough strategic review of their programs. "The proceeds of this
Humira, a TNF blocker used alone, with methotrexate, or with certain other medicines, will help prevent further damage to bones and joints. The randomised controlled Premier trial involved
The new clinical trial management system has key functionality to improve operations at sites and includes more automatic subject visit scheduling functionality and patient registry searches. The automated